Author:
Alkhalil Samia S.,Alosaimi Shoruq E.,Alosaimi Manal E.,Mohammedsaleh Zuhair M.,Al Abdulmonem Waleed,Alkhamiss Abdullah Saleh,Alghsham Ruqaih S.,Aljohani Abdullah S. M.,Shater Abdullah F.,Saleh Fayez M.,Almohaimeed Hailah M.,Soliman Mona H.
Publisher
Springer Science and Business Media LLC
Subject
Genetics,General Medicine
Reference26 articles.
1. Akash S, Khan MS, Mukerjee N, Bibi S (2023) Re-emergence of SARS-CoV-2 Omicron subvariant XBB. 1.5: present status, treatment, and future outlook–2023. Int J Surg 109(4):658
2. Bharadwaj KK, Sarkar T, Ghosh A et al (2021) Macrolactin A as a novel inhibitory agent for SARS-CoV-2 Mpro: bioinformatics approach. Appl Biochem Biotechnol 193:3371–3394. https://doi.org/10.1007/s12010-021-03608-7
3. Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossvary I, Moraes MA, Sacerdoti FD, Salmon JK (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. In Proceedings of the 2006 ACM/IEEE conference on supercomputing (pp. 84–es)
4. CDC (2021) Science Brief: Omicron (B.1.1.529) Variant. US Department of Health and Human Services, CDC; Atlanta, GA, USA. Available online: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-omicron-variant.html. Accessed 7 April 2023
5. Chinnasamy P, Arumugam R (2018) In silico prediction of anticarcinogenic bioactivities of traditional anti-inflammatory plants used by tribal healers in Sathyamangalam wildlife sanctuary. India Egypt J Basic Appl Sci 5(4):265–279